首页 › 基金 › Occam Crest Management LP › CABA

Occam Crest Management LP 对 CABA 的持仓历史

CABALETTA BIO INC · 医疗保健

Occam Crest Management LP 在 Q3 2026 的 13F 申报中披露持有 CABA(CABALETTA BIO INC)1,190,000 股,市值约 US$2.3M,约占其申报组合的 1.29%,在其申报持仓中市值排名第 20 位。 Occam Crest Management LP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)1.19M 股
申报持仓市值$2.28M
组合权重1.29%
首次申报Q3 2026
最近变动新进
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Occam Crest Management LP 对 CABA 的持仓演变

Occam Crest Management LP 于 Q3 2026 首次披露 CABA 持仓:1,190,000 股(约 US$2.3M)。

逐季持仓明细

季度股数金额变化
Q3 2026 1.19M $2.28M 新进

关于 CABA 与 13F 数据

CABA(CABALETTA BIO INC)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 CABA,申报仓位最大的包括:Bain Capital Life Sciences Investors, LLC (US$53.6M), Cormorant Asset Management, LP (US$15.6M), Opaleye Management Inc. (US$12.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CABA 的基金

查看 CABA 的全部基金持有人 →

常见问题

How long has Occam Crest Management LP held CABA?

Occam Crest Management LP has disclosed CABA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Occam Crest Management LP's current position in CABA?

As of Q3 2026, Occam Crest Management LP holds 1.19M shares of CABA (CABALETTA BIO INC), valued at $2.28M, representing 1.29% of its reported portfolio and ranking #20.

Has Occam Crest Management LP been buying or selling CABA?

In the latest 13F filing (Q3 2026), Occam Crest Management LP newly opened its position in CABA.

Which other funds hold CABA?

Other major institutional holders of CABA include Bain Capital Life Sciences Investors, LLC, Cormorant Asset Management, LP, Opaleye Management Inc., among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.